Literature DB >> 12873591

Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.

Mohamad A Eloubeidi1, Michael B Wallace, Renee Desmond, Francis A Farraye.   

Abstract

OBJECTIVE: Flexible sigmoidoscopy (FS) screening for colorectal cancer (CRC) is associated with reduced mortality from CRC. It is unknown whether FS is equally effective in men and women, but differences in anatomy and perception of pain may increase the difficulty of performing FS in women. The aim of this study was to determine factors associated with a shorter or limited screening FS.
METHODS: Patients referred by their primary care provider were eligible for screening sigmoidoscopy if they were 50 yr or older with negative fecal occult blood tests and no first-degree relative with colorectal cancer at age 55 yr or younger. A detailed questionnaire regarding demographic characteristics and risk factors for CRC, aspirin and multivitamin use, and previous abdominal surgery was completed by the patient on a standardized form before their procedure. The histologic type (hyperplastic, adenoma, normal mucosa, or carcinoma) of each polyp was recorded. Depth of examination (in cm) was recorded based on the standardized markings on the shaft of the sigmoidoscope when it was thought to be in a straight position. Limitations to the examination (angulation, pain, and poor preparation), other mucosal findings, and complications were also noted.
RESULTS: A total of 3980 patients (52% female) were prospectively enrolled in a screening program over a 22-month period. Women were more likely than men to report previous pelvic or abdominal surgery (OR = 2.64, 95% CI = 2.29-3.05) and were less likely to have had a previous sigmoidoscopy (OR = 0.71, 95% CI = 0.61-0.83). Females were almost twice as likely as males to have a procedure limited in some way (angulation, spasm, or pain) (OR = 1.86, 95% CI = 1.63-2.13). When defined by depth of examination, females were significantly more likely than males to have a procedure of <50 cm (OR = 1.93, 95% CI = 1.63, 2.29) and were less likely to have an adenomatous polyp or cancer detected (OR = 0.55, 95% CI = 0.42-0.71). The average endoscopy distance for women was 52.3 cm, compared with 55.2 cm in men (p < 0.0001), and the average number of polyps detected in women was 1.4, compared with 1.56 in men (p = 0.003) among patients with at least one polyp. Using multivariable analysis, females were more likely to have an examination of <50 cm compared with men, controlling for age, spasm or pain on examination, previous surgery, angulation of the colon, and type of endoscopist-MD or nonphysician endoscopist (OR = 1.67, 95% CI = 1.41-1.99).
CONCLUSIONS: Women are more likely than men to have a shorter and more limited FS. This is partly owing to increased colonic angulation and pain during the examination. Methods aimed at reducing pain and improving maneuverability in an angulated colon during FS may improve the effectiveness of CRC screening in women.

Entities:  

Mesh:

Year:  2003        PMID: 12873591     DOI: 10.1111/j.1572-0241.2003.07480.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

1.  Flexible sigmoidoscopy for colorectal cancer screening in the elderly.

Authors:  Ajay Pabby; Anupam Suneja; Timothy Heeren; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

2.  Concerns and challenges in flexible sigmoidoscopy screening.

Authors:  Akeem O Adebogun; Christine D Berg; Adeyinka O Laiyemo
Journal:  Colorectal Cancer       Date:  2012-08

3.  Optical measurement of rectal microvasculature as an adjunct to flexible sigmoidosocopy: gender-specific implications.

Authors:  Hemant K Roy; Andrew J Gomes; Sarah Ruderman; Laura K Bianchi; Michael J Goldberg; Valentina Stoyneva; Jeremy D Rogers; Vladimir Turzhitsky; Young Kim; Eugene Yen; Mohammed Jameel; Andrej Bogojevic; Vadim Backman
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-22

4.  Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

Authors:  Adeyinka O Laiyemo; Chyke Doubeni; Paul F Pinsky; V Paul Doria-Rose; Andrew K Sanderson; Robert Bresalier; Joel Weissfeld; Robert E Schoen; Pamela M Marcus; Philip C Prorok; Christine D Berg
Journal:  Cancer Epidemiol       Date:  2011-11-22       Impact factor: 2.984

5.  Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Authors:  Joel L Weissfeld; Robert E Schoen; Paul F Pinsky; Robert S Bresalier; V Paul Doria-Rose; Adeyinka O Laiyemo; Timothy Church; Lance A Yokochi; Susan Yurgalevitch; Joshua Rathmell; Gerald L Andriole; Saundra Buys; E David Crawford; Mona Fouad; Claudine Isaacs; Lois Lamerato; Douglas Reding; Philip C Prorok; Christine D Berg
Journal:  J Natl Cancer Inst       Date:  2012-01-31       Impact factor: 13.506

6.  Is There a Place for Screening Flexible Sigmoidoscopy?

Authors:  Doron Boltin; Yaron Niv
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03

Review 7.  Colorectal cancer screening and prevention in women.

Authors:  Lyssa Chacko; Carole Macaron; Carol A Burke
Journal:  Dig Dis Sci       Date:  2015-01-18       Impact factor: 3.199

8.  Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer.

Authors:  V P Doria-Rose; P A Newcomb; T R Levin
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

9.  The effects of teamwork and system support on colorectal cancer screening in primary care practices.

Authors:  Shawna V Hudson; Pamela Ohman-Strickland; Regina Cunningham; Jeanne M Ferrante; Karissa Hahn; Benjamin F Crabtree
Journal:  Cancer Detect Prev       Date:  2007-11-26

10.  Toward the Elimination of Colorectal Cancer Disparities Among African Americans.

Authors:  Steven S Coughlin; Daniel S Blumenthal; Shirley Jordan Seay; Selina A Smith
Journal:  J Racial Ethn Health Disparities       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.